ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 66 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,747,000 | -9.3% | 763,212 | -2.5% | 0.01% | 0.0% |
| Q2 2021 | $4,133,000 | +5.9% | 782,812 | -3.7% | 0.01% | 0.0% |
| Q1 2021 | $3,901,000 | +0.3% | 812,612 | -9.6% | 0.01% | +25.0% |
| Q4 2020 | $3,891,000 | +14.6% | 898,584 | +9.1% | 0.00% | +33.3% |
| Q3 2020 | $3,395,000 | +53.8% | 824,004 | -4.4% | 0.00% | +50.0% |
| Q2 2020 | $2,207,000 | +91.7% | 862,254 | +116.4% | 0.00% | +100.0% |
| Q1 2020 | $1,151,000 | +3.7% | 398,380 | +36.1% | 0.00% | 0.0% |
| Q4 2019 | $1,110,000 | +75.6% | 292,780 | +136.8% | 0.00% | 0.0% |
| Q3 2019 | $632,000 | -77.5% | 123,635 | -62.4% | 0.00% | -66.7% |
| Q4 2018 | $2,810,000 | -41.6% | 329,081 | +93.7% | 0.00% | -70.0% |
| Q4 2015 | $4,812,000 | -7.6% | 169,900 | -45.4% | 0.01% | -16.7% |
| Q3 2015 | $5,206,000 | -16.8% | 311,000 | +30.3% | 0.01% | -14.3% |
| Q2 2015 | $6,257,000 | +735.4% | 238,633 | +457.6% | 0.01% | +600.0% |
| Q1 2015 | $749,000 | – | 42,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 984,329 | $6,999,000 | 4.03% |
| Broadfin Capital, LLC | 2,469,894 | $17,561,000 | 3.63% |
| Healthcare Value Capital, LLC | 100,000 | $711,000 | 2.74% |
| ARMISTICE CAPITAL, LLC | 2,744,000 | $19,510,000 | 1.07% |
| DELTEC ASSET MANAGEMENT LLC | 536,836 | $3,817,000 | 0.84% |
| SECTORAL ASSET MANAGEMENT INC | 808,924 | $5,751,000 | 0.69% |
| Mosaic Family Wealth, LLC | 91,314 | $649,000 | 0.26% |
| Worth Venture Partners, LLC | 59,740 | $425,000 | 0.24% |
| EMERALD ADVISERS, LLC | 626,247 | $4,453,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 565,319 | $4,019,000 | 0.16% |